
Strides Pharma Science Limited has informed the Exchange regarding a press release dated March 19, 2021, titled "RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine".
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange regarding a press release dated March 19, 2021, titled "RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine".
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science